At the end of the latest market close, Predictive Oncology Inc. (POAI) was valued at $0.79. In that particular session, Stock kicked-off at the price of $0.8026 while reaching the peak value of $0.90 and lowest value recorded on the day was $0.7739. The stock current value is $0.90.
Recently in News on January 8, 2021, Predictive Oncology Announces $3,074,007 Registered Direct Offering Priced At-The-Market under Nasdaq Rules. Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that it has entered into definitive agreements with several institutional and accredited investors for the issuance and sale of an aggregate of 3,650,840 shares of its common stock, at a purchase price of $0.842 per share, for gross proceeds of approximately $3.0 million in a registered direct offering priced at-the-market under Nasdaq rules. Predictive Oncology has also agreed to issue to the investors unregistered warrants to purchase an aggregate of up to 1,825,420 shares of common stock. The closing of the offering is expected to occur on or about January 12, 2021, subject to the satisfaction of customary closing conditions. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Predictive Oncology Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $0.9000 on 01/11/21, with the lowest value was $0.7100 for the same time period, recorded on 01/08/21.
Predictive Oncology Inc. (POAI) full year performance was -64.29%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Predictive Oncology Inc. shares are logging -83.02% during the 52-week period from high price, and 42.84% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.63 and $5.30.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3160002 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Predictive Oncology Inc. (POAI) recorded performance in the market was 22.87%, having the revenues showcasing 11.10% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 16.06M, as it employees total of 29 workers.
Analysts verdict on Predictive Oncology Inc. (POAI)
During the last month, 0 analysts gave the Predictive Oncology Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.8024, with a change in the price was noted -0.3401. In a similar fashion, Predictive Oncology Inc. posted a movement of -27.43% for the period of last 100 days, recording 1,226,975 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for POAI is recording 0.48 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Predictive Oncology Inc. (POAI): Technical Analysis
Raw Stochastic average of Predictive Oncology Inc. in the period of last 50 days is set at 93.07%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 92.56%. In the last 20 days, the company’s Stochastic %K was 66.46% and its Stochastic %D was recorded 60.29%.
Let’s take a glance in the erstwhile performances of Predictive Oncology Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 22.87%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -37.51%, alongside a downfall of -64.29% for the period of the last 12 months. The shares increased approximately by 24.99% in the 7-day charts and went up by 18.83% in the period of the last 30 days. Common stock shares were driven by 11.10% during last recorded quarter.